Orexins as novel therapeutic targets in inflammatory and neurodegenerative diseases

A Couvineau, T Voisin, P Nicole, V Gratio… - Frontiers in …, 2019 - frontiersin.org
Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by
the hypothalamus. The main biological actions of orexins, focused on the central nervous …

Involvement of the orexinergic system in cancer: Antitumor strategies and future perspectives

P Marcos, R Coveñas - Applied Sciences, 2023 - mdpi.com
Peptides promote the mitogenesis and migration of tumor cells, and cancer cells
overexpress peptide receptors. The involvement of the orexinergic system in cancer is …

N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome

V De Pasquale, A Esposito, G Scerra… - Journal of Medicinal …, 2023 - ACS Publications
Sanfilippo syndrome comprises a group of four genetic diseases due to the lack or
decreased activity of enzymes involved in heparan sulfate (HS) catabolism. HS …

[HTML][HTML] Hypocretin-1 suppresses malignant progression of glioblastoma cells through Notch1 signaling pathway

R Huan, J Yue, J Lan, J Wang, Y Cheng, J Zhang… - Brain Research …, 2023 - Elsevier
Hypocretin-1 is a multifunctional neuropeptide that has been identified as a potential
antitumor agent for its role in inhibiting tumor growth, including in colon cancer …

Neuropeptides in Cancer: Friend and Foe?

Y Wu, A Berisha, JC Borniger - Advanced Biology, 2022 - Wiley Online Library
Neuropeptides are small regulatory molecules found throughout the body, most notably in
the nervous, cardiovascular, and gastrointestinal systems. They serve as neurotransmitters …

Focus on the complex interconnection between cancer, narcolepsy and other neurodegenerative diseases: a possible case of orexin-dependent inverse comorbidity

MP Mogavero, A Silvani, LM DelRosso, M Salemi… - Cancers, 2021 - mdpi.com
Simple Summary This narrative review first describes from several points of view the
complex interrelationship between cancer and neurodegeneration, with special attention to …

Orexins/hypocretins and cancer: a neuropeptide as emerging target

C Alain, N Pascal, G Valérie, V Thierry - Molecules, 2021 - mdpi.com
Over 20 years ago, orexin neuropeptides (Orexin-A/hypocretin-1 and Orexin-B/hypocretins-
2) produced from the same precursor in hypothalamus were identified. These two …

Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives

A Costagliola, R Lombardi, G Liguori… - Cancer Genomics & …, 2023 - cgp.iiarjournals.org
Prostate cancer (PCa) is the second most common cancer in humans. Peptides have
recently been used as targeted therapeutics in cancers, due to their extensive multi …

Orexin A suppresses the expression of exosomal PD-L1 in colon cancer and promotes T cell activity by inhibiting JAK2/STAT3 signaling pathway

J Wen, X Chang, B Bai, Q Gao, Y Zhao - Digestive diseases and sciences, 2022 - Springer
Background Colon cancer, ranked third in cancer related mortality, is the most common
malignant cancer of digestive tract. Though immune checkpoint inhibitors show promising …

The anti-tumoral properties of orexin/hypocretin hypothalamic neuropeptides: an unexpected therapeutic role

A Couvineau, S Dayot, P Nicole, V Gratio… - Frontiers in …, 2018 - frontiersin.org
Orexins (OxA and OxB) also termed hypocretins are hypothalamic neuropeptides involved in
central nervous system (CNS) to control the sleep/wake process which is mediated by two G …